サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1701663

自家ワクチンの世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Autogenous Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 214 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
自家ワクチンの世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年04月08日
発行: Persistence Market Research
ページ情報: 英文 214 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の自家ワクチンの市場規模は、2025年に1億5,210万米ドルになるとみられ、2025年～2032年の予測期間に5.4%のCAGRで拡大し、2032年には2億1,970万米ドルに達すると予測されています。

自家ワクチンは、特定の個体または群れから分離された特定の病原体用に開発されたカスタムメイドのワクチンであり、主に獣医学で使用されます。これらのワクチンは、家畜や伴侶動物の感染症を制御する上で重要な役割を果たしています。市場は、動物病院、動物保健センター、農場、研究所に供給され、家禽、豚、牛、水産養殖の各分野で需要が増加しています。市場の拡大には、動物の健康に対する懸念の高まり、規制の柔軟性、特に感染症の発生が一般的な地域における精密な獣医学的ケアへの注目の高まりが寄与しています。

世界の自家ワクチン市場は、人獣共通感染症や家畜伝染病の発生率の上昇、標的を絞った群特異的な予防接種の必要性などの主な要因によって牽引されています。これらのワクチンは、標準的な市販ワクチンでは対処できないような病原体の地方株に対処するための効果的なソリューションを提供します。高品質の動物性タンパク質に対する需要の高まり、家畜の生産性の向上、抗生物質不使用の食肉製品に対する消費者の嗜好が、自家ワクチンの採用をさらに後押ししています。規制当局の支援や、獣医師や家畜所有者の間でカスタマイズされた疾病管理に対する認識が高まっていることも、市場の持続的成長に寄与しています。さらに、水産養殖産業の成長が、種特異的な自家ワクチンの新たな需要を生み出しています。

良好な成長動向にもかかわらず、自家ワクチン市場は、製造コストの高さ、ワクチン開発期間の長期化、製造方法の標準化の遅れなど、いくつかの抑制要因に直面しています。これらのワクチンはオーダーメイドであるため、大量生産の拡張性の欠如はサプライチェーンの効率や費用対効果に影響を与える可能性があります。さらに、地域によって規制が異なるため、国際取引や市場拡大に課題があります。特に新興国市場においては、小規模農家における自家ワクチンの特典に関する認識が不十分であり、病原体同定のための高度な診断ツールの利用可能性が限られていることも、市場浸透へのさらなる障害となっています。

自家ワクチン市場は、病原体同定、ワクチン製剤化、個別化された獣医学的ケアにおける技術的進歩により、大きな機会をもたらします。次世代シーケンシングと分子診断ツールの採用により、病原体プロファイリングのスピードと精度が向上し、迅速なワクチン開発が促進されます。抗菌薬耐性の低減が重視されるようになり、持続可能な畜産へのシフトは、自家ワクチンの新たな成長の道を開きます。動物用ワクチンメーカー、診断研究所、学術機関の戦略的提携は、市場の能力を拡大する可能性が高いです。さらに、特に新興市場では、動物衛生イニシアティブに対する政府支援の増加や獣医学インフラへの投資が需要を押し上げると予想されます。

当レポートでは、世界の自家ワクチン市場について調査し、株タイプ別、動物タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値のある洞察

第4章 世界の自家ワクチン市場の見通し

  • 主なハイライト
  • 市場規模分析と予測
    • 過去の市場規模分析、2019年～2024年
    • 現在の市場規模分析と予測、2025年～2032年
  • 世界の自家ワクチン市場の見通し：株タイプ別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、株タイプ別、2019年～2024年
    • 現在の市場規模分析と予測、株タイプ別、2025年～2032年
    • 市場の魅力分析：株タイプ別
  • 世界の自家ワクチン市場の見通し：動物タイプ別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、動物タイプ別、2019年～2024年
    • 現在の市場規模分析と予測、動物タイプ別、2025年～2032年
    • 市場の魅力分析：動物タイプ別
  • 世界の自家ワクチン市場の見通し：エンドユーザー別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、エンドユーザー別、2019年～2024年
    • 現在の市場規模分析と予測、エンドユーザー別、2025年～2032年
    • 市場の魅力分析：エンドユーザー別

第5章 世界の自家ワクチン市場の見通し：地域別

  • 主なハイライト
  • 過去の市場規模分析、地域別、2019年～2024年
  • 現在の市場規模分析と予測、地域別、2025年～2032年
    • 北米
    • 欧州
    • 東アジア
    • 南アジアとオセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第6章 北米の自家ワクチン市場の見通し

第7章 欧州の自家ワクチン市場の見通し

第8章 東アジアの自家ワクチン市場の見通し

第9章 南アジアおよびオセアニアの自家ワクチン市場の見通し

第10章 ラテンアメリカの自家ワクチン市場の見通し

第11章 中東・アフリカの自家ワクチン市場の見通し

第12章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • Phibro Animal Health Corporation,
    • Ceva
    • Boehringer Ingelheim International GmbH
    • Elanco
    • Addison Biological Laboratory
    • Bioveta, as
    • Vaxxinova
    • ARKO Laboratories
    • Dopharma
    • HIPRA
    • Cambridge Technologies
    • IDT Biologika.
    • HYGIEIA BIOLOGICAL LABORATORIES
    • Lohmann Breeders
    • Design Biologix.
    • Deltamune
    • Bimeda（R）Biologicals
    • Others

第13章 付録

目次
Product Code: PMRREP29491

Persistence Market Research has recently released a comprehensive report on the worldwide market for Autogenous Vaccines. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global autogenous vaccines market from 2025 to 2032.

Key Insights:

  • Autogenous Vaccines Market Size (2025E): USD 152.1 Million
  • Projected Market Value (2032F): USD 219.7 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.4%

Autogenous Vaccines Market - Report Scope:

Autogenous vaccines are custom-made vaccines developed for specific pathogens isolated from a particular individual or herd, primarily used in veterinary medicine. These vaccines play a vital role in controlling infectious diseases in livestock and companion animals when commercial vaccines are ineffective or unavailable. The market serves veterinary clinics, animal health centers, farms, and research laboratories, with increasing demand across poultry, swine, cattle, and aquaculture sectors. Market expansion is fueled by rising concerns over animal health, regulatory flexibility, and growing focus on precision veterinary care, particularly in regions where infectious disease outbreaks are common.

Market Growth Drivers:

The global autogenous vaccines market is driven by key factors including the increasing incidence of zoonotic and livestock diseases and the need for targeted, herd-specific immunization. These vaccines offer an effective solution for managing local strains of pathogens that may not be addressed by standard commercial vaccines. Rising demand for high-quality animal protein, enhanced livestock productivity, and consumer preference for antibiotic-free meat products further push the adoption of autogenous vaccines. Regulatory support and greater awareness among veterinarians and livestock owners regarding customized disease management also contribute to sustained market growth. Additionally, the growing aquaculture industry is generating new demand for species-specific autogenous vaccines.

Market Restraints:

Despite favorable growth trends, the autogenous vaccines market faces several restraints, including high production costs, extended timelines for vaccine development, and limited standardization in manufacturing practices. As these vaccines are tailor-made, the lack of mass production scalability can impact supply chain efficiency and cost-effectiveness. Furthermore, regulatory variations across different regions pose challenges for international trade and market expansion. Inadequate awareness about the benefits of autogenous vaccines among small-scale farmers, particularly in developing regions, and limited availability of advanced diagnostic tools for pathogen identification are additional hurdles to market penetration.

Market Opportunities:

The autogenous vaccines market presents significant opportunities driven by technological advancements in pathogen identification, vaccine formulation, and personalized veterinary care. The adoption of next-generation sequencing and molecular diagnostic tools enhances the speed and accuracy of pathogen profiling, facilitating rapid vaccine development. Growing emphasis on antimicrobial resistance reduction and the shift towards sustainable livestock farming open new growth avenues for autogenous vaccines. Strategic collaborations between veterinary vaccine manufacturers, diagnostic labs, and academic institutions are likely to expand the market's capabilities. Moreover, increasing government support for animal health initiatives and investment in veterinary infrastructure, especially in emerging markets, are expected to boost demand.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the autogenous vaccines market globally?
  • Which animal segments and applications are most influenced by autogenous vaccine adoption?
  • How are advancements in diagnostics and biotechnology impacting the development of autogenous vaccines?
  • Who are the key players contributing to the autogenous vaccines market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global autogenous vaccines market?

Competitive Intelligence and Business Strategy:

Leading players in the global autogenous vaccines market, including Ceva Sante Animale, Elanco Animal Health, and Phibro Animal Health Corporation, are emphasizing product customization, R&D investment, and geographic expansion to strengthen their market presence. These companies collaborate with veterinary professionals and research labs to develop herd-specific vaccines tailored to field-isolated pathogens. Investments in diagnostic technologies and integrated vaccine production platforms are enhancing speed-to-market and cost efficiency. Strategic acquisitions and regional partnerships further help key players expand their capabilities and penetrate untapped markets. Additionally, customer education initiatives and digital platforms are being leveraged to increase awareness and facilitate vaccine ordering and delivery.

Key Companies Profiled:

  • Newport Laboratories, Inc. (Boehringer Ingelheim International GmbH)
  • Elanco Animal Health
  • Phibro Animal Health Corporation
  • Ceva Sante Animale
  • ACE Laboratory Services (Apiam Animal Health)
  • Huvepharma, Inc.
  • AniCon Labor GmbH
  • Cambridge Technologies
  • Dyntec s. r. o
  • Hygieia Biological Laboratories
  • HIPRA
  • Vaxxinova
  • sanphar (ipeve)
  • Addison Biological Laboratory
  • Zoetis (PHARMAQ AS)
  • Barramundi Asia Pte Ltd.(UVAXX Asia)
  • Kennebec River Biosciences

Key Segments Covered in Autogenous Vaccines Industry Research

Product:

  • Bacterial Strain
  • Virus Strain

By Animal Type

  • Poultry
  • Swine
  • Fish
  • Horses
  • Others

End User:

  • Veterinary Research Institutes
  • Livestock Farming Companies
  • Veterinary Clinics and Hospitals

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Autogenous Vaccines Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Disease Epidemiology
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Autogenous Vaccines Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Autogenous Vaccines Market Outlook: Strain Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) and Analysis, By Strain Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
      • 4.3.3.1. Bacterial Strain
      • 4.3.3.2. Viral Strain
    • 4.3.4. Market Attractiveness Analysis: Strain Type
  • 4.4. Global Autogenous Vaccines Market Outlook: Animal Type
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Animal Type, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
      • 4.4.3.1. Poultry
      • 4.4.3.2. Swine
      • 4.4.3.3. Fish
      • 4.4.3.4. Horses
      • 4.4.3.5. Others
    • 4.4.4. Market Attractiveness Analysis: Animal Type
  • 4.5. Global Autogenous Vaccines Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.3.1. Veterinary Clinics and Hospitals
      • 4.5.3.2. Veterinary Research Institutes
      • 4.5.3.3. Livestock Farming Companies
      • 4.5.3.4. Aquaculture Farming
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global Autogenous Vaccines Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Autogenous Vaccines Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Strain Type
    • 6.2.3. By Animal Type
    • 6.2.4. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
    • 6.4.1. Bacterial Strain
    • 6.4.2. Viral Strain
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
    • 6.5.1. Poultry
    • 6.5.2. Swine
    • 6.5.3. Fish
    • 6.5.4. Horses
    • 6.5.5. Others
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.6.1. Veterinary Clinics and Hospitals
    • 6.6.2. Veterinary Research Institutes
    • 6.6.3. Livestock Farming Companies
    • 6.6.4. Aquaculture Farming
  • 6.7. Market Attractiveness Analysis

7. Europe Autogenous Vaccines Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Strain Type
    • 7.2.3. By Animal Type
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
    • 7.4.1. Bacterial Strain
    • 7.4.2. Viral Strain
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
    • 7.5.1. Poultry
    • 7.5.2. Swine
    • 7.5.3. Fish
    • 7.5.4. Horses
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Veterinary Clinics and Hospitals
    • 7.6.2. Veterinary Research Institutes
    • 7.6.3. Livestock Farming Companies
    • 7.6.4. Aquaculture Farming
  • 7.7. Market Attractiveness Analysis

8. East Asia Autogenous Vaccines Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Strain Type
    • 8.2.3. By Animal Type
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
    • 8.4.1. Bacterial Strain
    • 8.4.2. Viral Strain
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
    • 8.5.1. Poultry
    • 8.5.2. Swine
    • 8.5.3. Fish
    • 8.5.4. Horses
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Veterinary Clinics and Hospitals
    • 8.6.2. Veterinary Research Institutes
    • 8.6.3. Livestock Farming Companies
    • 8.6.4. Aquaculture Farming
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Autogenous Vaccines Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Strain Type
    • 9.2.3. By Animal Type
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
    • 9.4.1. Bacterial Strain
    • 9.4.2. Viral Strain
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
    • 9.5.1. Poultry
    • 9.5.2. Swine
    • 9.5.3. Fish
    • 9.5.4. Horses
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Veterinary Clinics and Hospitals
    • 9.6.2. Veterinary Research Institutes
    • 9.6.3. Livestock Farming Companies
    • 9.6.4. Aquaculture Farming
  • 9.7. Market Attractiveness Analysis

10. Latin America Autogenous Vaccines Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Strain Type
    • 10.2.3. By Animal Type
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
    • 10.4.1. Bacterial Strain
    • 10.4.2. Viral Strain
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
    • 10.5.1. Poultry
    • 10.5.2. Swine
    • 10.5.3. Fish
    • 10.5.4. Horses
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Veterinary Clinics and Hospitals
    • 10.6.2. Veterinary Research Institutes
    • 10.6.3. Livestock Farming Companies
    • 10.6.4. Aquaculture Farming
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Autogenous Vaccines Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Strain Type
    • 11.2.3. By Animal Type
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
    • 11.4.1. Bacterial Strain
    • 11.4.2. Viral Strain
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
    • 11.5.1. Poultry
    • 11.5.2. Swine
    • 11.5.3. Fish
    • 11.5.4. Horses
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Veterinary Clinics and Hospitals
    • 11.6.2. Veterinary Research Institutes
    • 11.6.3. Livestock Farming Companies
    • 11.6.4. Aquaculture Farming
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Phibro Animal Health Corporation,
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Ceva
    • 12.3.3. Boehringer Ingelheim International GmbH
    • 12.3.4. Elanco
    • 12.3.5. Addison Biological Laboratory
    • 12.3.6. Bioveta, a.s.
    • 12.3.7. Vaxxinova
    • 12.3.8. ARKO Laboratories
    • 12.3.9. Dopharma
    • 12.3.10. HIPRA
    • 12.3.11. Cambridge Technologies
    • 12.3.12. IDT Biologika.
    • 12.3.13. HYGIEIA BIOLOGICAL LABORATORIES
    • 12.3.14. Lohmann Breeders
    • 12.3.15. Design Biologix.
    • 12.3.16. Deltamune
    • 12.3.17. Bimeda(R) Biologicals
    • 12.3.18. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations